|
FANCM expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.759800E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.170500E-04 |
| Normal-vs-Stage2 |
6.122700E-03 |
| Normal-vs-Stage3 |
2.294200E-02 |
| Normal-vs-Stage4 |
2.735300E-03 |
| Stage1-vs-Stage2 |
8.794000E-01 |
| Stage1-vs-Stage3 |
4.609000E-01 |
| Stage1-vs-Stage4 |
4.720200E-01 |
| Stage2-vs-Stage3 |
4.937800E-01 |
| Stage2-vs-Stage4 |
5.982400E-01 |
| Stage3-vs-Stage4 |
2.485400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
9.94770000000145E-05 |
| Normal-vs-AfricanAmerican |
1.722260E-02 |
| Normal-vs-Asian |
5.611200E-01 |
| Caucasian-vs-AfricanAmerican |
2.930600E-01 |
| Caucasian-vs-Asian |
3.205400E-01 |
| AfricanAmerican-vs-Asian |
5.760800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.39279999999709E-05 |
| Normal-vs-Female |
8.496500E-02 |
| Male-vs-Female |
1.556370E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.682470E-03 |
| Normal-vs-Extreme_Weight |
1.029890E-04 |
| Normal-vs-Obese |
1.864110E-02 |
| Normal-vs-Extreme_Obese |
2.139800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.964200E-01 |
| Normal_Weight-vs-Obese |
2.848600E-01 |
| Normal_Weight-vs-Extreme_Obese |
6.913000E-01 |
| Extreme_Weight-vs-Obese |
4.243900E-02 |
| Extreme_Weight-vs-Extreme_Obese |
4.109000E-01 |
| Obese-vs-Extreme_Obese |
8.380800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.860000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.938190E-02 |
| Normal-vs-Age(61-80Yrs) |
1.79071999999447E-05 |
| Normal-vs-Age(81-100Yrs) |
1.74786000000093E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.858000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.175900E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.000600E-03 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.497100E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.562100E-04 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.572100E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.401700E-03 |
| Normal-VS-Type2 PRCC |
4.30650000000643E-05 |
| Normal-VS-KIRP CIMP |
1.891170E-01 |
| Normal-VS-Unclassified PRCC |
5.853500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
9.302100E-02 |
| Type1 PRCC-VS-KIRP CIMP |
8.582200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
7.876800E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.152200E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.968420E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
7.926400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.83290000000036E-05 |
| Normal-vs-N1 |
2.784200E-01 |
| Normal-vs-N2 |
2.623100E-03 |
| N0-vs-N1 |
2.900500E-02 |
| N0-vs-N2 |
3.118000E-01 |
| N1-vs-N2 |
1.013390E-01 |
|
|
